Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pleural Effusion, Malignant 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 2043Radiotherapy 1859Cisplatin 1826Carboplatin 1533Gemcitabine 1435Paclitaxel 1291Bevacizumab 1271Docetaxel 1202pembrolizumab 1201Oxaliplatin 1160Capecitabine 1145Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 864Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 609fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Interventional × Genes, fms × Clear all
NCT04806412 2022-05-17

Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study.

Naestved Hospital

Phase NA Unknown
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡